CHEK1 and neoplasm: Importantly, decreasing auto-phosphorylation of CHK1 at S296 was observed in drug-treated cells for both parental and resistant tumor lines, indicative that prexasertib was still inhibiting CHK1 kinase activity (Figure 6B).